Meeting Agenda (All Times Pacific)Register Now

 

Tuesday, October 15, 2024

Workshop A: Data Science and Artificial Intelligence

8:30     TBD
Mark A. Clements, MD, PhD, CPI, FAAP
Children’s Mercy Hospital, Kansas City, Missouri, USA

8:45     TBD
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA

9:00     TBD
Andrea Facchinetti, PhD
Department of Information Engineering, University of Padova, Padova, Italy

9:15     TBD
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA

9:30     TBD 
Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, MD

9:45     Q&A

10:00  BREAK

Workshop A: Real World Evidence for Diabetes Trials

10:30   Julia K. Mader, MD
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria

10:35   Rohit Vashisht, PhD
University of California, San Francisco, San Francisco, California, USA

10:40   Shahid Shah
Netspective Communications, Landover, Maryland, USA

10:45   Juan Espinoza, MD, FAAP
Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA

10:50   Panel Discussion

12:00   LUNCH

Workshop B: New Diagnostic Tests

13:15   TBD

13:30   Antibodies to Diagnose Diabetes
Zoe Quandt, MD
Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, California, USA

13:45   Continuous Insulin Monitoring
Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA

14:00   Cardiac Blood Pressure and Exercise Monitoring
Ambarish Pandey, MD
UT Southwestern Medical Center, Dallas, Texas, USA

14:15   Qualitative Hypoglycemia Detection
Gerard L. Coté, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA

14:30   Q&A

14:40   BREAK

Workshop B: Drugs, Insulin and Technology

15:10   Storage of Insulin
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany

15:25   Use of GLP-1 RAs Before Surgery
Sun H. Kim, MD
Department of Medicine – Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, California, USA

15:40   New Insulins
Zan Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA

15:55   TBD
TBD

16:10   TBD
TBD

16:25   Q&A

16:30  Poster Session

Wednesday, October 16, 2024

8:00     Welcome and Introduction
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

8:05     Keynote Presentation - How is the FDA OIVD evolving to regulate new technologies?
Marianela Perez-Torres, PhD
Director of Division of Chemistry and Toxicology Devices, U.S. Food and Drug Administration, Silver Spring, Maryland, USA

Session 1: Big Tech

8:30     Panelists

Erich Huang, MD, PhD
Verily, South San Francisco, California, USA

Alyssa Patel, PharmD, BCACP
Clinical Pharmacist, Chronic Care, One Medical, San Francisco, California, USA

Aiman Abdel-Malek, PhD
Thirdwayv Inc. and Apex Medical Ai Inc., La Jolla, CA

TBD

8:35     Panel Discussion

9:40     BREAK

Session 2: New Uses of CGMs

10:10   Nutrition Monitoring for Diabetes
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, California, USA

10:25   Use of CGMs by Elite Athletes
Howard Zisser

10:40   CGM for Prediabetes
Michael P. Snyder, PhD
Department of Genetics, Stanford University, Palo Alto, California, USA

10:55   Q&A

Session 3: Who Can Sell Your Data

11:05   An Oceania Perspective
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand

11:15   A European Perspective
Eva Winkler, MD, PhD
University of Heidelberg, Heidelberg, Germany

11:25   An Industry Perspective
Jamie E. Darch, JD
Ropes & Gray LLP, Chicago, Illinois, USA

11:35   A United States Perspective
Bonnie Odom, JD, MPH
Epstein Becker & Green, P.C., San Diego, California, USA

11:45   Q&A

12:00   LUNCH

Session 4: Payers/Economics for Digital Health Interventions

13:15   Panelists

Amanda Adler, MD, PhD, FRCP
Churchill Hospital, Oxford, United Kingdom

Warris Bokhari, MBBS
NewCo Health, Tempe, Arizona, USA

Jordan Silberman, MD, PhD
Elevance Health, Indianapolis, Indiana, USA

Paul Radensky, MD, JD
McDermot Will & Emery Consulting, Washington, DC, USA

13:20   Panel Discussion

Session 5: Analyzing Data from a CGM

14:15   Tight Time in Range
Peter Calhoun, PhD
Jaeb Center for Health Research, Tampa, Florida, USA

14:27   The Diabetes Data Dock
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

14:39   Glycemia Risk Index
Viral N. Shah, MD
Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA

14:51   Interpreting CGM Data with the GRI
Ralph Oiknine, MD

15:03   Q&A

15:15   BREAK

Session 6: How to Improve Artificial Pancreas Performance

15:45   Incorporating Exercise into Closed Loop Algorithms
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA

15:57   Female Fertility and AID performance: Menses and Pregnancy
Carol Levy, MD, CDCES
Division of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, New York, USA

16:09   Bihormonal Closed Loop Control
Steven J. Russell, MD, PhD
Massachusetts General Hospital Diabetes Research Center, Boston, Massachusetts, USA

16:21   The Use of GLP-1RAs with AIDs
Viral N. Shah, MD
Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA

16:33   Q&A

16:45   Poster Session

Thursday, October 17, 2024

Session 7: Can Tech Improve Adherence to Diabetes Rx?

8:00     A Summary of the 2024 NIDDK DHT in T2D Research Gaps Workshop
Henry B. Burch, MD
Program Director, Division of Diabetes, Endocrinology, & Metabolic Diseases,
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, MD

8:12     TBD
Paula Voorheis, PhD
Lunenfeld-Tanenebaum Research Institute, Sinai Health System

8:24     TBD
Wei-An (Andy) Lee, DO
Los Angeles General Medical Center, Los Angeles, California, USA

8:36     TBD  
William Polonsky, PhD
Behavioral Diabetes Institute & University of California, San Diego, San Diego, California, USA

8:48     Q&A

Session 8: Accuracy of Diabetes Devices

9:00     The New DTS Error Grid and Trend Accuracy Matrix
Michael Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA

9:15     Reliability and Comparability of CGM Performance Endpoints
Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany

9:30     Limitations of Using the MARD for Accuracy
Jan Krouwer, PhD
Krouwer Consulting, Sherborn, MA

9:45     Q&A

9:55     BREAK

Session 9: Innovation Challenge

10:25   Open Innovation Challenge
Diabetes Center Berne, Berne, Switzerland

11:30   LUNCH

Session 10: Physiology of Inserted and Implanted Devices

12:45   TBD
TBD
Embecta, Parsippany-Troy Hills, New Jersey, USA

12:57   Update on Optical Glucose Measurement
Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA

13:09   TBD
Irl B. Hirsch, MD
University of Washington, Seattle, Washington, USA

13:21   Implanted Technology for Measuring Glucose
Mark Tapsak, PhD
GlucoTrack, Rutherford, New Jersey, USA

13:33   Q&A

Session 11: Performance of a CGM

13:45   Update from Abbott
Mahmood Kazemi, MD
Abbott Diabetes Care, Chicago, Illinois, USA

13:55   Update from Dexcom
Jessica Castle, MD
Dexcom, Inc, San Diego, California, USA

14:05   Update from Roche
Timor Glatzer, PhD
Roche Diabetes Care, Inc, Indianapolis, Indiana, USA

14:15   Update from Senseonics
Hari Sree, PhD
Senseonics Inc., Germantown, Maryland, USA

14:25   TBD

14:35   Q&A

14:45   BREAK

Session 12: Hot Topics

15:15   ChatGPT Applied to Diabetes
Sultan A. Meo, MBBS, Ph.D, MMed Ed, FRCP
College of Medicine, King Saud University, Riyadh, Saudi Arabia

15:30   TBD
TBD

15:45   TBD
TBD

16:00   TBD
TBD

16:15   TBD
TBD

Session 13: Live Demonstration

16:20   TBD
TBD